Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID after Pfizer Shots; COVID after Pfizer Shots; This is a spontaneous report and received from Consumer or other non HCPs, Program ID: . A 66-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Mar2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "aneurysms" (unspecified if ongoing); "heart stents and in my brain" (unspecified if ongoing); "heart stents and in my brain" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 3, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 4, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 5, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 6, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 7, SINGLE), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID after Pfizer Shots".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500131177 same reporter/event; different patient/product;
Medical History/Concurrent Conditions: Aneurysm; Brain stent insertion; Cardiac stent placement